BioBridgeXAll companies

Pear Therapeutics, Inc.

Biotechnology company · Boston, Massachusetts, United States

Pear Therapeutics, Inc. is a biotechnology company headquartered in Boston, Massachusetts, United States. Its earliest recorded incorporation is in 2013. It has received 4 US government small-business research awards (SBIR/STTR) from health agencies, $1.5 million in total, most recently in 2019. It has reported private securities offerings to the US SEC, most recently $132 million sold in a notice filed in 2021.

Profile compiled from public records. Is this your company? Request a correction or update

Pear Therapeutics at a glance

Typebiotechnology company
HeadquartersBoston, Massachusetts, United States
Earliest incorporation on record2013
Employees (per SBIR records)120
SEC CIK1615898

What does Pear Therapeutics do?

US government research funding

4 SBIR/STTR small-business research awards from US health agencies, $1.5 million in total (2017 to 2019). NIH funding came from the National Institute on Drug Abuse.

Private fundraising reported to the SEC

5 Form D notices; the most recent reported $132 million sold (2021).

Frequently asked questions about Pear Therapeutics

Where is Pear Therapeutics headquartered?

Pear Therapeutics, Inc. is headquartered in Boston, Massachusetts, United States.

What does Pear Therapeutics do?

Pear Therapeutics, Inc. is a biotechnology company.

When was Pear Therapeutics founded?

The earliest incorporation on record for Pear Therapeutics, Inc. is in 2013, according to public company registers.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Sources

Location data: GeoNames (geonames.org), CC BY 4.0.

Last updated 2026-09-23.